2014
DOI: 10.2147/ott.s60114
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

Abstract: Abstract:The lack of therapy and the failure of existing therapy has been a challenge for clinicians in treating various cancers. Doxorubicin, 5-fluorouracil, cisplatin, and paclitaxel are the first-line therapy in various cancers; however, toxicity, resistance, and treatment failure limit their clinical use. Their status leads us to discover and investigate more targeted therapy with more efficacy. In this article, we dissect literature from the patient perspective, the tumor biology perspective, therapy-indu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
190
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 250 publications
(209 citation statements)
references
References 93 publications
7
190
1
Order By: Relevance
“…Interestingly, NFkB-IL6 signaling has been implicated in the self-renewal, chemoresistance, and tumorigenesis (14,(44)(45)(46)(47). The involvement of NFkB-IL6 signaling in our ex vivo and in vitro models prompted us to evaluate the role of aspirin in abrogating this pathway to chemosensitize resistant breast tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, NFkB-IL6 signaling has been implicated in the self-renewal, chemoresistance, and tumorigenesis (14,(44)(45)(46)(47). The involvement of NFkB-IL6 signaling in our ex vivo and in vitro models prompted us to evaluate the role of aspirin in abrogating this pathway to chemosensitize resistant breast tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Activation of NF-κB and resultant inflammatory response have been noted after tumor or host cell exposure to at least five drugs other than PXL including doxorubicin, 5-fluoracil (5-FU), oxaliplatin, cyclophosphamide (CTX), and cisplatin (36). Similarly to PXL, stimulation of the NF-κB pathway by these drugs led to activation of the MAPK pathway, upregulation of the pro-inflammatory AP-2 transcription factor (37), and overexpression of inflammatory (36), prosurvival (29), and migratory genes (38). The TLR4 dependent inflammatory response induced by various chemodrugs was also implicated in promoting epithelial-mesenchymal transition (36) and selecting tumor cells with the stem-like phenotype (39).…”
Section: Introductionmentioning
confidence: 99%
“…ADR has previously been shown to induce inflammation in some cancer line by elevation of some inflammatory markers, e.g., IL-1, TNF-α, and NF-KB. NF-κB is also activated by p53 in inflammation induced by ADR [31].…”
Section: Discussionmentioning
confidence: 99%